In TCGA cohort, Kaplan–Meier survival analysis revealed that increased COL5A2 and UNC5B expression indicated a worse prognosis in patients with osteosarcoma (Figures 11A,E), but HOXB4 expression was not linked with patients’ clinical fate (Figure 11C). The gene discussed is COL5A2; the disease is osteosarcoma.